Á¦2ȸ ¾È¿°Áõ ½ÉÆ÷Áö¾ö (Çѱ¹°¢¸·ÇÐȸ Çѱ¹Æ÷µµ¸·ÇÐȸ °øµ¿ÁÖ°ü) : 2023-10-28
±³À°ÀÏÀÚ : 2023-10-28
±³À°Àå¼Ò : ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ
±³À°ÁÖÁ¦ : Á¦2ȸ ¾È¿°Áõ ½ÉÆ÷Áö¾ö (Çѱ¹°¢¸·ÇÐȸ Çѱ¹Æ÷µµ¸·ÇÐȸ °øµ¿ÁÖ°ü)
ÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹Æ÷µµ¸·ÇÐȸ
´ã´çÀÚ : Á¶À翵
¿¬¶ôó : 02-6403-4300
À̸ÞÀÏ : jyjomtl@naver.com
±³À°Á¾·ù : ¾È°ú
Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í »çÀüµî·Ï : Á¤È¸¿ø Àü¹®ÀÇ (¹«·á) / ºñȸ¿ø Àü¹®ÀÇ 30,000¿ø / Àü°øÀÇ µî ¹«·áÇöÀåµî·Ï : Á¤È¸¿ø Àü¹®ÀÇ 40,000¿ø / ºñȸ¿ø Àü¹®ÀÇ 40,000¿ø / Àü°øÀÇ 30,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 08:50~09:00 °³È¸»ç ¹× Àλ縻¾¸ ÇÔµ·ÀÏ ÀÌÇü±Ù ȸÀå(Çѱ¹Æ÷µµ¸·ÇÐȸ ¹× Çѱ¹°¢¸·ÇÐȸ)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 09:00~09:20 Role of ACAID in anterior segment inflammation ÃÖ¹®Á¤(Àϻ꺴¿ø)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 09:20~09:40 Metagenomics in uveitis ÀÌÁØ¿ø(¿¬¼¼´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 09:40~10:00 Neuro-immune crosstalk in the corneal inflammation ÃÖ¿µÁØ(¾ÆÁÖ´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 10:00~10:20 AI in uveitis Á¶¹üÁÖ(ÇѸ²´ë)
ÈÞ½Ä 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 10:20~10:35 ÈÞ½Ä -(-)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 10:35~10:55 Anterior scleritis ±è¼±¿õ(¿¬¼¼´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 10:55~11:15 Posterior scleritis ¿ì¼¼ÁØ(¼¿ï´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 11:15~11:35 Management of anterior segment inflammation associated with autoimmune disorders ÀÌÇö¼ö(°¡Å縯´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 11:35~11:55 Management of posterior segment inflammation associated with autoimmune disorders ¹Ú¼ºÈÄ(ºÎ»ê´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 11:55~12:25 Clinical/basic approaches to corneal endotheliitis Dai Miyazaki(Tottori University)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 12:25~12:55 Ophthalmic Characteristics of Behçet Disease Radgonde Amer(Hadassah Medical Center)
Åä·Ð 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 12:55~13:10 ÅäÀÇ -(-)
½Ä»ç 10¿ù 28ÀÏ 13:10~14:10 Á¡½É -(-)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 14:10~14:30 Guidelines for the use of systemic immunosuppressants in ocular inflammatory diseases ¿ÀÁÖ¿¬(¼¿ï´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 14:30~14:50 CMV PCR in anterior uveitis; is it a necessity? ÀÌ°æ¹Î(°¡Å縯°üµ¿´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 14:50~15:10 Herpes simplex virus vs varicella zoster virus : similar but different ±èµ¿Çö(°í·Á´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 15:10~15:30 Ocular inflammation associated with targeted chemotherapy ±èÀ±Àü(¿ï»ê´ë)
ÈÞ½Ä 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 15:30~15:40 ÈÞ½Ä -(-)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 15:40~15:50 Human breast milk-derived exosomes ameliorate the ocular surface inflammation in a rabbit dry eye model Áö¿ë¿ì(¿¬¼¼´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 15:50~16:00 Paradoxical Duo of M1 and M2 Macrophages in Pterygium Lymphangiogenesis ±è°æ¿ì(Áß¾Ó´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 16:00~16:10 Transient corneal edema after successful DMEK with satisfactory postoperative visual acuity: What happens in clear DMEK graft? ÀÌÈÆ(¿ï»ê´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 16:10~16:20 Serial changes in the aqueous IL-10 level as an indicator of primary vitreoretinal lymphoma recurrence; a single tertiary center experience ¹Ú¿µ±Ù(°¡Å縯´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 16:20~16:30 Secondary retinal vasoproliferative tumor in a patient with retinitis pigmentosa ±èÀº¾Æ(ÀÎÁ¦´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 16:30~16:40 Clinical characteristics of patients with Possner-Schlossman syndrome ±è¹ÎÈ£(¾Ð±¸Á¤¼º¸ð¾È°ú)
±âŸ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 16:40~16:45 Æóȸ»ç ±è¼±¿õ(¿¬¼¼´ë)